Category: Renal

Clinical Correlations

FDA Black Box Warning on Gadolinium

Breaking News Renal 1 min read

Back in December we reported on the FDA cautioning practioners about the use of gadolinium (an mri contrast agent) in patients with chronic kidney disease.  The FDA is now requesting a black box warning  stating “that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, …

Read More